Collection of biological parameters

PreclinicalBiologic

Collection of biological parameters is one of 15 biologic programs targeting Eating Disorder. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Eating DisorderActive, not recruiting

Eating DisorderPreclinical

Active, not recruiting

Competition

Competitive Landscape

16 competitors in Eating Disorder

#DrugCompanyPhaseTrials

Atarax

Pfizer

Approved

1 2

Cymbalta

Jazz Pharmaceuticals

Approved

1 3

Namenda

AbbVie

Approved

1 4

Victoza

Novo Nordisk

Approved

—5

Sunosi

AAxsome Therapeutics, Inc.

Approved

1 6

Strattera

MMap77

Approved

1 7

Zyprexa

MMODAG GmbH

Approved

—8

Zonegran

AAzurity Pharmaceuticals

Approved

—9

E-Mycin

AAzurity Pharmaceuticals

Approved

—10

Adzenys Er

AAzurity Pharmaceuticals

Approved

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q3 2027

N/ANot yet recruiting

Eating Disorder

NCT07295470

Clinical

Trials by Indication[1]

Eating Disorder1 trial

Sleep and Activity For Eating Disorders

Not yet recruiting·IIstituto Auxologico Italiano·N/A·NCT07295470·75 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Collection of biological parameters. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Collection of biological parameters compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Collection of biological parameters. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Istituto Auxologico Italiano company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Highest Phase: Preclinical[1]
Company: IIstituto Auxologico Italiano

Collection of biological parameters

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q3 2027

Trials by Indication[1]

Eating Disorder1 trial

References

Drug Info

Quick Facts

Related News